Literature DB >> 32924569

Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney.

Justin L Grodin1, W H Wilson Tang2.   

Abstract

Entities:  

Keywords:  Editorials; heart failure; kidney

Year:  2020        PMID： 32924569      PMCID： PMC7495489          DOI： 10.1161/CIRCULATIONAHA.120.048057

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease.

Authors:  C David Mazer; Gregory M T Hare; Philip W Connelly; Richard E Gilbert; Nadine Shehata; Adrian Quan; Hwee Teoh; Lawrence A Leiter; Bernard Zinman; Peter Jüni; Fei Zuo; Nikhil Mistry; Kevin E Thorpe; Ronald M Goldenberg; Andrew T Yan; Kim A Connelly; Subodh Verma
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

Review 2.  Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.

Authors:  Hiddo J L Heerspink; Bruce A Perkins; David H Fitchett; Mansoor Husain; David Z I Cherney
Journal:  Circulation       Date:  2016-07-28       Impact factor: 29.690

3.  Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).

Authors:  Justin L Grodin; Jie-Lena Sun; Kevin J Anstrom; Horng H Chen; Randall C Starling; Jeffrey M Testani; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2016-09-30       Impact factor: 2.778

4.  Cardioprotection conferred by sodium-glucose cotransporter 2 inhibitors: a renal proximal tubule perspective.

Authors:  Danúbia Silva Dos Santos; Juliano Z Polidoro; Flávio A Borges-Júnior; Adriana C C Girardi
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

5.  Glucose-induced regulation of NHEs activity and SGLTs expression involves the PKA signaling pathway.

Authors:  Olívia Beloto-Silva; Ubiratan Fabres Machado; Maria Oliveira-Souza
Journal:  J Membr Biol       Date:  2010-12-08       Impact factor: 1.843

6.  Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.

Authors:  S Sha; D Polidori; T Heise; J Natarajan; K Farrell; S-S Wang; D Sica; P Rothenberg; L Plum-Mörschel
Journal:  Diabetes Obes Metab       Date:  2014-07-08       Impact factor: 6.577

7.  Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.

Authors:  Graziella Badin Aliti; Eneida R Rabelo; Nadine Clausell; Luís E Rohde; Andreia Biolo; Luis Beck-da-Silva
Journal:  JAMA Intern Med       Date:  2013-06-24       Impact factor: 21.873

8.  Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.

Authors:  K Melissa Hallow; Peter J Greasley; Gabriel Helmlinger; Lulu Chu; Hiddo J Heerspink; David W Boulton
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-18

Review 9.  Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys.

Authors:  Motoaki Sano; Makoto Takei; Yasuyuki Shiraishi; Yoshihiko Suzuki
Journal:  J Clin Med Res       Date:  2016-10-26

10.  Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.

Authors:  Christopher S Wilcox; Wen Shen; David W Boulton; Bruce R Leslie; Steven C Griffen
Journal:  J Am Heart Assoc       Date:  2018-02-10       Impact factor: 5.501
View more
  2 in total

1.  The roles of sodium and volume overload on hypertension in chronic kidney disease.

Authors:  Jinho Shin; Chang Hwa Lee
Journal:  Kidney Res Clin Pract       Date:  2021-11-17

2.  Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population.

Authors:  Weijia Li; Adarsh Katamreddy; Rachna Kataria; Merle L Myerson; Cynthia C Taub
Journal:  Drugs Real World Outcomes       Date:  2021-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.